STAR and breast carcinoma: Given that TPD52 is closely associated with tumor progression, our study here identified a clearly regulatory relationship that Star-PAP regulates the expression of TPD52 via modulating miR-449a/34a, rather than the direct 3′-end processing way in breast cancer cells (Fig. 2E).